Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue
<p>Abstract</p> <p>Background</p> <p>There is resurgence within drug and biomarker development communities for the use of primary tumorgraft models as improved predictors of patient tumor response to novel therapeutic strategies. Despite perceived advantages over cell l...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-06-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | http://www.translational-medicine.com/content/10/1/125 |
| _version_ | 1818527664254746624 |
|---|---|
| author | Monsma David J Monks Noel R Cherba David M Dylewski Dawna Eugster Emily Jahn Hailey Srikanth Sujata Scott Stephanie B Richardson Patrick J Everts Robin E Ishkin Aleksandr Nikolsky Yuri Resau James H Sigler Robert Nickoloff Brian J Webb Craig P |
| author_facet | Monsma David J Monks Noel R Cherba David M Dylewski Dawna Eugster Emily Jahn Hailey Srikanth Sujata Scott Stephanie B Richardson Patrick J Everts Robin E Ishkin Aleksandr Nikolsky Yuri Resau James H Sigler Robert Nickoloff Brian J Webb Craig P |
| author_sort | Monsma David J |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>There is resurgence within drug and biomarker development communities for the use of primary tumorgraft models as improved predictors of patient tumor response to novel therapeutic strategies. Despite perceived advantages over cell line derived xenograft models, there is limited data comparing the genotype and phenotype of tumorgrafts to the donor patient tumor, limiting the determination of molecular relevance of the tumorgraft model. This report directly compares the genomic characteristics of patient tumors and the derived tumorgraft models, including gene expression, and oncogenic mutation status.</p> <p>Methods</p> <p>Fresh tumor tissues from 182 cancer patients were implanted subcutaneously into immune-compromised mice for the development of primary patient tumorgraft models. Histological assessment was performed on both patient tumors and the resulting tumorgraft models. Somatic mutations in key oncogenes and gene expression levels of resulting tumorgrafts were compared to the matched patient tumors using the OncoCarta (Sequenom, San Diego, CA) and human gene microarray (Affymetrix, Santa Clara, CA) platforms respectively. The genomic stability of the established tumorgrafts was assessed across serial <it>in vivo</it> generations in a representative subset of models. The genomes of patient tumors that formed tumorgrafts were compared to those that did not to identify the possible molecular basis to successful engraftment or rejection.</p> <p>Results</p> <p>Fresh tumor tissues from 182 cancer patients were implanted into immune-compromised mice with forty-nine tumorgraft models that have been successfully established, exhibiting strong histological and genomic fidelity to the originating patient tumors. Comparison of the transcriptomes and oncogenic mutations between the tumorgrafts and the matched patient tumors were found to be stable across four tumorgraft generations. Not only did the various tumors retain the differentiation pattern, but supporting stromal elements were preserved. Those genes down-regulated specifically in tumorgrafts were enriched in biological pathways involved in host immune response, consistent with the immune deficiency status of the host. Patient tumors that successfully formed tumorgrafts were enriched for cell signaling, cell cycle, and cytoskeleton pathways and exhibited evidence of reduced immunogenicity.</p> <p>Conclusions</p> <p>The preservation of the patient’s tumor genomic profile and tumor microenvironment supports the view that primary patient tumorgrafts provide a relevant model to support the translation of new therapeutic strategies and personalized medicine approaches in oncology.</p> |
| first_indexed | 2024-12-11T06:39:03Z |
| format | Article |
| id | doaj.art-d3c026f9b7994d7fb965af542eaa7f14 |
| institution | Directory Open Access Journal |
| issn | 1479-5876 |
| language | English |
| last_indexed | 2024-12-11T06:39:03Z |
| publishDate | 2012-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Translational Medicine |
| spelling | doaj.art-d3c026f9b7994d7fb965af542eaa7f142022-12-22T01:17:17ZengBMCJournal of Translational Medicine1479-58762012-06-0110112510.1186/1479-5876-10-125Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissueMonsma David JMonks Noel RCherba David MDylewski DawnaEugster EmilyJahn HaileySrikanth SujataScott Stephanie BRichardson Patrick JEverts Robin EIshkin AleksandrNikolsky YuriResau James HSigler RobertNickoloff Brian JWebb Craig P<p>Abstract</p> <p>Background</p> <p>There is resurgence within drug and biomarker development communities for the use of primary tumorgraft models as improved predictors of patient tumor response to novel therapeutic strategies. Despite perceived advantages over cell line derived xenograft models, there is limited data comparing the genotype and phenotype of tumorgrafts to the donor patient tumor, limiting the determination of molecular relevance of the tumorgraft model. This report directly compares the genomic characteristics of patient tumors and the derived tumorgraft models, including gene expression, and oncogenic mutation status.</p> <p>Methods</p> <p>Fresh tumor tissues from 182 cancer patients were implanted subcutaneously into immune-compromised mice for the development of primary patient tumorgraft models. Histological assessment was performed on both patient tumors and the resulting tumorgraft models. Somatic mutations in key oncogenes and gene expression levels of resulting tumorgrafts were compared to the matched patient tumors using the OncoCarta (Sequenom, San Diego, CA) and human gene microarray (Affymetrix, Santa Clara, CA) platforms respectively. The genomic stability of the established tumorgrafts was assessed across serial <it>in vivo</it> generations in a representative subset of models. The genomes of patient tumors that formed tumorgrafts were compared to those that did not to identify the possible molecular basis to successful engraftment or rejection.</p> <p>Results</p> <p>Fresh tumor tissues from 182 cancer patients were implanted into immune-compromised mice with forty-nine tumorgraft models that have been successfully established, exhibiting strong histological and genomic fidelity to the originating patient tumors. Comparison of the transcriptomes and oncogenic mutations between the tumorgrafts and the matched patient tumors were found to be stable across four tumorgraft generations. Not only did the various tumors retain the differentiation pattern, but supporting stromal elements were preserved. Those genes down-regulated specifically in tumorgrafts were enriched in biological pathways involved in host immune response, consistent with the immune deficiency status of the host. Patient tumors that successfully formed tumorgrafts were enriched for cell signaling, cell cycle, and cytoskeleton pathways and exhibited evidence of reduced immunogenicity.</p> <p>Conclusions</p> <p>The preservation of the patient’s tumor genomic profile and tumor microenvironment supports the view that primary patient tumorgrafts provide a relevant model to support the translation of new therapeutic strategies and personalized medicine approaches in oncology.</p>http://www.translational-medicine.com/content/10/1/125TumorgraftsGenomicsTranslational models |
| spellingShingle | Monsma David J Monks Noel R Cherba David M Dylewski Dawna Eugster Emily Jahn Hailey Srikanth Sujata Scott Stephanie B Richardson Patrick J Everts Robin E Ishkin Aleksandr Nikolsky Yuri Resau James H Sigler Robert Nickoloff Brian J Webb Craig P Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue Journal of Translational Medicine Tumorgrafts Genomics Translational models |
| title | Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue |
| title_full | Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue |
| title_fullStr | Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue |
| title_full_unstemmed | Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue |
| title_short | Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue |
| title_sort | genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue |
| topic | Tumorgrafts Genomics Translational models |
| url | http://www.translational-medicine.com/content/10/1/125 |
| work_keys_str_mv | AT monsmadavidj genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT monksnoelr genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT cherbadavidm genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT dylewskidawna genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT eugsteremily genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT jahnhailey genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT srikanthsujata genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT scottstephanieb genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT richardsonpatrickj genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT evertsrobine genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT ishkinaleksandr genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT nikolskyyuri genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT resaujamesh genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT siglerrobert genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT nickoloffbrianj genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue AT webbcraigp genomiccharacterizationofexplanttumorgraftmodelsderivedfromfreshpatienttumortissue |